HealthEquity (NASDAQ:HQY) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

HealthEquity (NASDAQ:HQY) posted its quarterly earnings results on Tuesday. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05, FiscalAI reports. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. The business’s revenue was up 7.3% compared to the same quarter last year.

HealthEquity Price Performance

NASDAQ:HQY traded up $0.73 during mid-day trading on Tuesday, hitting $79.40. 1,262,885 shares of the company’s stock traded hands, compared to its average volume of 854,441. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The firm’s 50 day simple moving average is $81.30 and its 200 day simple moving average is $90.27. HealthEquity has a 1 year low of $72.76 and a 1 year high of $116.65. The company has a market cap of $6.78 billion, a PE ratio of 25.13, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.

Insider Buying and Selling at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Sivia Capital Partners LLC bought a new position in shares of HealthEquity during the second quarter worth about $306,000. Arrowstreet Capital Limited Partnership bought a new position in HealthEquity during the 2nd quarter valued at $4,747,000. Marshall Wace LLP acquired a new position in HealthEquity during the second quarter worth about $5,483,000. Amundi lifted its stake in HealthEquity by 9.3% during the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after purchasing an additional 2,574 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in shares of HealthEquity during the 2nd quarter valued at $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HQY shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a research note on Friday, December 5th. Raymond James Financial set a $100.00 price target on HealthEquity in a research report on Tuesday, February 17th. Barclays reduced their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research report on Thursday, February 19th. Finally, The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research report on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $112.00.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.